MEDAMI 2017 - V MEDITERRANEAN FORUM ON ADVANCED MOLECULAR IMAGING

Material Package

Added Since

Include only attachments uploaded after this date

Include*

Everything

Specific sessions

Specific contributions

Specific days

Sessions*

ROUND TABLE - The relation of academia and industry in the development of medical and molecular imaging technologies. Chair: Paul. Lecoq, CERN - Representatives of funding institutions, industries, MDs, physicists/technologists Outcome: proposals for improvement of academia-industry relation

Session 2.2: Brain biomarkers and brain imaging initiatives

Session 2.3: Brain imaging - new technologies

ROUND TABLE - Molecular imaging and -omics: competition or complementarity for Precision medicine? Chair: Vesna Sossi, UBC, Vancouver Representatives of funding institutions, industries, MDs, physicists/technologists

Poster Session

Session 1.3: Diagnostic Imaging, theranostics and the -omics (Moderators: Bernd Pichler, Jonathan Disselhorst)

Session 1.3 (cont)

Welcome addresses

Session 3.1 (cont)

Session 1.1: Introductory Session (Moderator: Franco Garibaldi)

Session 1.2: Research concepts/activities (Moderator: York Haemisch)

Poster Session

Session 2.1: Neurodegenerative diseases and brain disorders

Session 3.1: New Technologies for Molecular Imaging

Session 5.2: Molecular Imaging in Hadron Therapy Monitoring

Session 3.2: Molecular Imaging in the diagnosis, treatment and follow up of breast cancer

Session 3.3: Technologies for breast imaging/diagnosis

Conference Excursion

Session 4.1: Molecular Imaging in the management of prostate cancer

ROUND TABLE - Multimodality multiparametric imaging in cancer management: How can it be improved? (Chair: David Townsend, Singapore)

Departure (first bus leaves)

Closing remarks (TBD)

Session 5.1: Molecular Imaging in surgical interventions

Conference Dinner

Include materials from selected sessions

Contributions*

Alberto del Guerra (Department of Physics, University of Pisa) - A trimodality (EEG/MR/PET) scanner for brain imaging (in session "Session 2.3: Brain imaging - new technologies")

Bernd Pichler (Dept. of Pre-clinical imaging and Radiopharmacy University of Tuebingen) - Combining multiparametric imaging data with –omics information for precision medicine (in session "Session 1.3: Diagnostic Imaging, theranostics and the -omics (Moderators: Bernd Pichler, Jonathan Disselhorst)")

Bernd Pichler (Director, Dept. of Pre-clinical imaging and Radiopharmacy, University of Tuebingen) - Developments in MRI, MEG and EEG (in session "Session 2.3: Brain imaging - new technologies")

Bernd Stowasser (Sanofi-Aventis, on behalf of the European Federation of Pharmaceutical Industries and Associations (EFPIA)) - Academic-Industry partnership: Can the IMI PPP model be extended/exported to medical imaging industry? (in session "Session 1.1: Introductory Session (Moderator: Franco Garibaldi)")

Bipin Singh (RMD Watertown, Ma) - Photonic Crystal Enhances Scintillation Light Extraction: Can It Improve Timing Resolution? (in session "Session 3.1 (cont)")

Charles R.G. Guttman (Center for Neurological Imaging, Harvard Medical School) - Neurodegenerative diseases - an overview (in session "Session 2.1: Neurodegenerative diseases and brain disorders")

Christer Halldin (Karolinska Institutet, Stockholm) - PET Radioligands for Neuroscience and Drug Development (in session "Session 2.2: Brain biomarkers and brain imaging initiatives")

Claudio Piemonte (FBK Trento) - New high performance SiPM arrays with TSV technology for TOF and other applications (in session "Session 3.1 (cont)")

Constantin Lapa (Nuclear Medicine, University of Wurzburg) - Theranostics and multimodality imaging (in session "Session 1.3: Diagnostic Imaging, theranostics and the -omics (Moderators: Bernd Pichler, Jonathan Disselhorst)")

Contributions (in session "Session 2.3: Brain imaging - new technologies")

David Townsend (National University of Singapore) - PET/CT, PET/MR and Precision Medicine: some alternative facts (in session "Session 1.3: Diagnostic Imaging, theranostics and the -omics (Moderators: Bernd Pichler, Jonathan Disselhorst)")

Dennis Schaart (Department of Rad. Science & Technology, TU Delft) - Fundamentals of Ultrafast Timing (in session "Session 3.1: New Technologies for Molecular Imaging")

Elena Solfaroli (Università degli Studi di Roma La Sapienza) - Radioguided surgery with beta-radiation: test on ex-vivo specimen (in session "Session 5.1: Molecular Imaging in surgical interventions")

Evaristo Cisbani (ISS and INFN, Roma) - A novel SPECT-Thomosynthesis detector for the diagnosis and follow up of breast cancer (in session "Session 3.3: Technologies for breast imaging/diagnosis")

F. Pennazio, INFN Torino) - The INSIDE project: hadron therapy monitoring with in-beam PET (in session "Session 5.2: Molecular Imaging in Hadron Therapy Monitoring")

Fijs van Leuven (LUMC, Leiden) - Multimodality imaging techniques in surgery (in session "Session 5.1: Molecular Imaging in surgical interventions")

Franco Garibaldi (AIB, Roma) - TOF-PET-MR in the diagnosis and follow up of the prostate cancer (in session "Session 4.1: Molecular Imaging in the management of prostate cancer")

Gabriela Llosa (Instituto de Fisica Corpuscular, University of Valencia) - From MACACO to MACACO II: a Compton telescope for hadron therapy treatment monitoring (in session "Session 3.1 (cont)")

H. Van der Pohel (Amsterdam, Ne) - Multimodality imaging in surgery (in session "Session 4.1: Molecular Imaging in the management of prostate cancer")

Ilan Rabiner (Chief Medical Officer, Head of Imaging Applications, Imanova Ltd., UK) - Building the Three Pillars- Imaging in early phase drug development (in session "Session 2.2: Brain biomarkers and brain imaging initiatives")

Ilaria Mattei (INFN Milano) - Characterisation of the secondary fast and ultrafast neutrons emitted in Particle Therapy with the MONDO experiment (in session "Session 3.1 (cont)")

Ilaria Mattei (INFN Milano) - Study of the radiation produced by therapeutic He, C and O ion beams impinging on a PMMA target for beam range monitoring purpose in Particle Therapy (in session "Session 5.2: Molecular Imaging in Hadron Therapy Monitoring")

Image guided robotic surgery in lung cancer. (... to be decided) (in session "Session 5.1: Molecular Imaging in surgical interventions")

Jonathan A. Disselhorst (University Tuebingen) - Imaging Tumor Heterogeneity (in session "Session 1.3 (cont)")

Jose Maria Benlloch (Institute of Molecular Imaging, University of Valencia) - Mindview: multimodal imaging of neurological disorders (in session "Session 2.3: Brain imaging - new technologies")

Marco Paganoni (Univ. of Milano) - ERAMIT (in session "Session 1.2: Research concepts/activities (Moderator: York Haemisch)")

Martin Walter (University of Tuebingen, Germany) -Multimodal imaging in psychiatry (in session "Session 2.1: Neurodegenerative diseases and brain disorders")

Maurizio Conti (Siemens Healthineers, Knoxville) - Challenges and trends in molecular imaging, an industry research viewpoint. The role of radiotracers in modern diagnosis and expensive/advanced therapies (in session "Session 1.2: Research concepts/activities (Moderator: York Haemisch)")

Michael O’ Connor (Mayo Clinic Rochester) - Breast cancer screening with single gamma and positron emitters (in session "Session 3.2: Molecular Imaging in the diagnosis, treatment and follow up of breast cancer")

Michel Herranz (Univ. of Santiago de Compostela) - Dedicated breast PET (dbPET) in diagnosis and follow up of breast cancer - comparison, synergies and divergences with MRI (in session "Session 3.3: Technologies for breast imaging/diagnosis")

Nicolas Petrick (Center for Devices and Radiological Health (CDRH), Food and Drug Administration (FDA)) - FDA perspective on the role of FDA in the emerging field of precision medicine medical imaging (in session "Session 1.1: Introductory Session (Moderator: Franco Garibaldi)")

Nicoletta Protti (INFN Pavia) - In vivo 10B imaging and dose rate measurement for Boron Neutron Capture Therapy (BNCT) using Single Photon Emission Computed Tomography (BNCT-SPECT) (in session "Session 4.1: Molecular Imaging in the management of prostate cancer")

Orazio Schillaci (TOV Policlinico Tor Vergata, Roma) - The role of Nuclear Medicine in breast cancer management (in session "Session 3.2: Molecular Imaging in the diagnosis, treatment and follow up of breast cancer")

P. Cerello (INFN Torino) - Imaging in hadron therapy (in session "Session 5.2: Molecular Imaging in Hadron Therapy Monitoring")

P. Pevsner - How cost-effectiveness of a diagnostic medical imaging procedure is determined (in session "Session 1.3 (cont)")

Paul Lecoq (CERN, Geneva) - ENDO-TOF-PET-US in the diagnosis and follow up of prostate cancer (in session "Session 4.1: Molecular Imaging in the management of prostate cancer")

Paul Lecoq (CERN, Geneva) - The 10 ps TOF-PET challenge (in session "Session 3.1: New Technologies for Molecular Imaging")

Paul M. Matthews (Head of Brain Imaging Sciences, Imperial College, London) - Challenges and opportunities for brain imaging with large population datasets (in session "Session 2.2: Brain biomarkers and brain imaging initiatives")

Piotr Maniawski (Philips Healthcare, Cleveland) - Digital Photon Counting PET: technology powering precision molecular imaging (in session "Session 3.1: New Technologies for Molecular Imaging")

Piotr Maniawski (Philips Healthcare, on behalf of the Association of Imaging Producers and Equipment Suppliers (AIPES)) - The AIPES organization and its role in supporting medical imaging development (in session "Session 1.2: Research concepts/activities (Moderator: York Haemisch)")

Roderic Pettigrew (Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB)) - Multimodality/Multiparametric Imaging and Precision Medicine (in session "Session 1.3 (cont)")

Simone Sarasso (Dept. of Biomedical Sciences, University of Milano) - Major brain initiatives (in session "Session 2.2: Brain biomarkers and brain imaging initiatives")

Stan Majewski (University of Virginia) - Dedicated PET brain imaging devices (in session "Session 2.3: Brain imaging - new technologies")

Stefaan Tavernier (PETsys Electronics SA, Lisbon) - TOFPET II: The next generation ASIC for TOF-applications (in session "Session 3.1 (cont)")

Terry Jones (UCL, London) - The Explorer project: a new paradigm in nuclear medicine? (in session "Session 3.1: New Technologies for Molecular Imaging")

Tobias Maurer (Klinikum rechts der Isar, TU Munich) - PSMA radioguided surgery – a novel technique for intraoperative detection of prostate cancer metastases (in session "Session 5.1: Molecular Imaging in surgical interventions")

Tobias Maurer (Klinikum rechts der Isar, TU Munich) - Shifting gears in Imaging - how PSMA-PET is about to change prostate cancer diagnosis (in session "Session 4.1: Molecular Imaging in the management of prostate cancer")

Valentina Garibotto (Univ.of Geneva) - Multimodal/multiparamenter imaging – main modalities and applications: link to biomarkers and personalized medicine (in session "Session 2.1: Neurodegenerative diseases and brain disorders")

Valeria Panebianco (Università degli Studi di Roma La Sapienza) - The role of multiparametric MR in the diagnosis and follow up of prostate cancer (in session "Session 4.1: Molecular Imaging in the management of prostate cancer")

Vesna Sossi (University of British Columbia) - PET/MRI imaging in neurodegeneration: novel metrics for early disease detection and effect of therapy assessment (in session "Session 2.1: Neurodegenerative diseases and brain disorders")

Volkmar Schulz (University of Aachen, DE) - PET-MR dedicated detector for breast cancer diagnosis and follow – up (in session "Session 3.3: Technologies for breast imaging/diagnosis")

Include materials from selected contributions

Events scheduled on*

31/05/2017

01/06/2017

02/06/2017

03/06/2017

04/06/2017

Include materials from sessions/contributions scheduled on the selected dates